Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Monday's Intraday Session

 

Gainers

  • MiNK Therapeutics (NASDAQ:INKT) shares moved upwards by 92.2% to $3.29 during Monday's regular session. As of 13:30 EST, MiNK Therapeutics's stock is trading at a volume of 3.0 million, which is 3237.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $110.2 million. As per the news, the Q2 earnings report came out 4 days ago.
  • Viridian Therapeutics (NASDAQ:VRDN) shares rose 55.87% to $22.96. Viridian Therapeutics's stock is trading at a volume of 10.8 million shares as of 13:30 EST. This is 3127.7% of its average full-day volume over the last 100 days. The company's market cap stands at $641.2 million. The company's, Q2 earnings came out today.
  • Plus Therapeutics (NASDAQ:PSTV) stock increased by 33.47% to $0.7. The current volume of 55.9 million shares is 66804.3% of Plus Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $16.2 million.
  • Terns Pharma (NASDAQ:TERN) stock increased by 32.28% to $4.0. As of 13:30 EST, Terns Pharma's stock is trading at a volume of 3.2 million, which is 1342.2% of its average full-day volume over the last 100 days. The company's market cap stands at $101.3 million.
  • Accelerate Diagnostics (NASDAQ:AXDX) shares moved upwards by 21.46% to $2.58. As of 13:30 EST, this security is trading at a volume of 1.9 million shares, making up 186.9% of its average full-day volume over the last 100 days. The company's market cap stands at $204.5 million. As per the news, the Q2 earnings report came out today.
  • Babylon Holdings (NYSE:BBLN) stock rose 20.3% to $0.92. The current volume of 894.6K shares is 85.8% of Babylon Holdings's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $389.3 million. The company's, Q2 earnings came out 4 days ago.

Losers

  • IDEAYA Biosciences (NASDAQ:IDYA) stock fell 34.5% to $10.25 during Monday's regular session. IDEAYA Biosciences's stock is trading at a volume of 1.6 million shares as of 13:30 EST. This is 602.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $396.0 million. As per the press release, Q2 earnings came out today.
  • Gelesis Holdings (NYSE:GLS) shares declined by 18.41% to $1.33. Trading volume for this security as of 13:30 EST is 90.3K, which is 82.1% of its average full-day volume over the last 100 days. The company's market cap stands at $96.3 million. As per the press release, Q2 earnings came out today.
  • MyMD Pharmaceuticals (NASDAQ:MYMD) shares decreased by 16.41% to $4.39. MyMD Pharmaceuticals's stock is trading at a volume of 325.1K shares as of 13:30 EST. This is 150.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $167.0 million.
  • LogicBio Therapeutics (NASDAQ:LOGC) shares fell 14.75% to $0.53. As of 13:30 EST, this security is trading at a volume of 372.6K shares, making up 160.5% of its average full-day volume over the last 100 days. The company's market cap stands at $17.4 million. The company's, Q2 earnings came out today.
  • Sensus Healthcare (NASDAQ:SRTS) stock fell 13.97% to $12.88. Sensus Healthcare's stock is trading at a volume of 998.3K shares as of 13:30 EST. This is 412.4% of its average full-day volume over the last 100 days. The company's market cap stands at $213.2 million.
  • PLx Pharma (NASDAQ:PLXP) shares decreased by 13.36% to $1.42. Trading volume for PLx Pharma's stock is 792.7K as of 13:30 EST. This is 361.1% of its average full-day volume over the last 100 days. The company's market cap stands at $39.1 million. As per the news, the Q2 earnings report came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.